Hematology Diagnostics Market- Prevalence of Blood-Related Disorders to Propel Demand
Hematology refers to a diagnostic bifurcation of cells found in the blood, which is helpful for easy and effective identification of various disease-causing pathogens. The process of hematology diagnosis consists of the calculation of RBC, WBC, and platelet count with the help of Hematology analyzers and reagents.
The hematology diagnosis process is associated with effective monitoring of diseases, prognosis & diagnosis, and subsequent screening. Growing prevalence of blood-related disorders and rising demand for technologically-advanced methodologies are among the prime factors fuelling investments in hematology diagnosis market.
Rising consolidation among leading market players & diagnostic laboratories is another chief aspect predominantly responsible for growth of hematology diagnostics market over the forecast period. Ever-evolving expansion of the hematology diagnostics market can be ascribed to rise in prevalence of blood-related disorders, which, in turn, results in augmented demand for effective diagnostics, such as hematology diagnostics.
Hematology Diagnostics Market- Manufacturers to Focus on Novel Product Developments Aligned with End-User Requirements
Sensing varying requirements of end-users, the manufacturers operating in the hematology market are vying to offer new products such as hematology analyzers and flow cytometers well-aligned with end-user requirements. This is resulting in an extensive inflow of new analyzers and combinations with effective functionalities and testing parameters. Moreover, key companies operating in the hematology diagnostics market are vying to be cost-competitive by commercializing their products at competitive prices.
With on-going developments in the flow cytometry procedures and techniques, manufacturers in the hematology diagnostics market are offering differential equipment for effective identification and detection of immature cells. In addition, with various improvement in case of electronic-fluidic systems, demand from laboratories for compact and cost-effective hematology diagnostics equipment is significantly taking off.
Hematology Diagnostics Market- Ubiquitous Demand for Medical Tourism to Boost Growth
Affordability combined with easy accessibility of effective healthcare services is resulting in heightened demand for medical tourism and medical equipment, including hematology diagnostics systems. Growing prevalence of blood-associated disorders in remote areas and skyrocketing demand for effective diagnosis via medical tourism is likely to provide impetus to growth of hematology diagnostics market.
Availability of latest and advanced equipment & technologies has restored the confidence of patients to opt for medical tourism hubs, creating opportunities for manufacturers in hematology diagnostics market.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Hematology Diagnostics Market- North America Continues to Retain its Lucrativeness, US and Canada to Offer Profit-Making Opportunities
North America continues to retain its position as a lucrative market for hematology diagnostics, offering sustained opportunities for the key stakeholders of hematology diagnostics market. With a major chunk of the global market share in 2017, multimodal factors, including advancements in healthcare space, high awareness ratio, and favorable reimbursement scenarios, are making North America a profitable region in the hematology diagnostics market space.
The U.S. & Canada continue to be progressive North American countries staying at the forefront of research and technological innovations, offering immense scope for revenue growth of hematology diagnostics market. This, in turn, is encouraging the participants of hematology diagnostics market to expand their foothold and tap into new customer segments across the key countries of North America.
Hematology Diagnostics Market- The Competitive Landscape
The report on hematology diagnostics market profiles key companies operating in the global market space, by analyzing their key differential strategies. Some of the leading players operating in the hematology diagnostics market include Sysmex Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Mindray Medical International Limited, Sysmex Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers, HemoCue AB, HORIBA, Ltd., Danaher (Beckman Coulter, Inc.), and others.
The leading market players are investing in research and development and embracing advanced technologies, with an objective of diversifying their product portfolio, expanding their customer outreach, and extend their regional presence.
On the basis of product type
- hematology consumables
- hematology instruments
On the basis of end-user
- diagnostic laboratories
- academic institutes
- hospitals & clinics
On the basis of region
- North America
- Asia Pacific
- Latin America
- MEA (Middle East & Africa)